Improved Insight Into Resistance Mechanisms to Imatinib in Gastrointestinal Stromal Tumors: A Basis for Novel Approaches and Individualization of Treatment
Oncologist - United States
doi 10.1634/theoncologist.12-6-719
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2007
Authors
Publisher
Alphamed Press